The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Morphine and alternative opioids in cancer pain: the EAPC recommendations
Open accessAbstract
An expert working group of the European Association for Palliative Care has revised and updated its guidelines on the use of morphine in the management of cancer pain. The revised recommendations presented here give guidance on the use of morphine and the alternative strong opioid analgesics which have been introduced in many parts of the world in recent years. Practical strategies for dealing with difficult situations are described presenting a consensus view where supporting evidence is lacking. The strength of the evidence on which each recommendation is based is indicated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breakthrough pain: definition, prevalence and characteristics
Portenoy, R. K., & Hagen, N. A. (1990) · Pain · doi:10.1016/0304-3959(90)90004-w · Cited by 933
Epidural clonidine analgesia for intractable cancer pain
Eisenach, J. C., DuPen, S., Dubois, M., Miguel, R., & Allin, D. (1995) · Pain · doi:10.1016/0304-3959(94)00209-w · Cited by 533
The WHO Analgesic Ladder for Cancer Pain Management: Stepping Up the Quality of Its Evaluation
Jadad, A. R. (1995) · JAMA · doi:10.1001/jama.1995.03530230056031 · Cited by 453
McQuay, H. (1999) · The Lancet · doi:10.1016/s0140-6736(99)03528-x · Cited by 414
Self-citationOpioid rotation for toxicity reduction in terminal cancer patients
de Stoutz, N. D., Bruera, E., & Suarez-Almazor, M. (1995) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(95)90924-c · Cited by 382
Ripamonti, C., Groff, L., Brunelli, C., Polastri, D., Stavrakis, A., & De Conno, F. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.10.3216 · Cited by 345
Self-citationClinical Pharmacokinetics of Morphine
Glare, P. A., & Walsh, T. D. (1991) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199101000-00001 · Cited by 290
Morphine and oxycodone hydrochloride in the management of cancer pain
Kalso, E., & Vainio, A. (1990) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1990.85 · Cited by 261
Self-citationDriving ability in cancer patients receiving long-term morphine analgesia
Vainio, A., Rosenberg, P., Kalso, E., Ollila, J., & Matikainen, E. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92281-4 · Cited by 220
Self-citationBruera, E., Belzile, M., Pituskin, E., Fainsinger, R., Darke, A., Harsanyi, Z., Babul, N., & Ford, I. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.10.3222 · Cited by 204
Säwe, J. (1986) · Clinical Pharmacokinetics · doi:10.2165/00003088-198611020-00001 · Cited by 194
Hoskin, P., Hanks, G., Aherne, G. W., Chapman, D., Littleton, P., & Filshie, J. (1989) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1989.tb05399.x · Cited by 170
Self-citationPain treatment and outcomes for patients with advanced cancer who receive follow-up care at home
Mercadante, S. (1999) · Cancer · Cited by 146
Self-citationMoulin, D. E., Murray-Parsons, N., Bouquillon, A., & Kreeft, J. H. (1991) · The Lancet · doi:10.1016/0140-6736(91)93401-t · Cited by 145
ABSORPTION AND BIOAVAILABILITY OF NEBULIZED MORPHINE
CHRUBASIK, J., Wüst, H., FRIEDRICH, G. E., & Geller, E. (1988) · British Journal of Anaesthesia · doi:10.1093/bja/61.2.228 · Cited by 132
Conno, F. D., Groff, L., Brunelli, C., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.10.2836 · Cited by 118
Self-citationEXPLANATION FOR POTENCY OF REPEATED ORAL DOSES OF MORPHINE?
Hanks, G. W., Aherne, G. W., Hoskin, P., Turner, P., & Poulain, P. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91083-x · Cited by 115
Self-citationEstimation of methadone clearance: application in the management of cancer pain
Plummer, J. L., Gourlay, G. K., Cherry, D. A., & Cousins, M. J. (1988) · Pain · doi:10.1016/0304-3959(88)90290-4 · Cited by 110
Peak Plasma Concentrations After Oral Morphine
Collins, S., Faura, C. C., Moore, R. A., & McQuay, H. J. (1998) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(98)00094-3 · Cited by 109
Self-citationPain relief in advanced cancer
Twycross, R. (1994) · Churchill Livingstone eBooks · Cited by 90
Self-citationPain Relief in Advanced Cancer
Hanks, G. W. (1995) · BMJ · doi:10.1136/bmj.310.6990.1340a · Cited by 89
Self-citationRectal, Buccal, and Sublingual Narcotics for the Management of Cancer Pain
Ripamonti, C. I., & Bruera, E. D. (1991) · Journal of Palliative Care · doi:10.1177/082585979100700105 · Cited by 54
Self-citationSyringe driver in terminal care.
Dover, S. B. (1987) · BMJ · doi:10.1136/bmj.294.6571.553 · Cited by 40
Twycross, R. (1984) · Journal of the Royal College of Physicians of London · doi:10.1016/s0035-8819(25)02601-7 · Cited by 31
Self-citationOpioid Problems, and Morphine Metabolism and Excretion
McQuay, H. J., & Moore, R. A. (1997) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-60777-6_13 · Cited by 16
Self-citationThe Therapeutic Equivalence of IM and PO Administration of Morphine – 1:3 or 1:6?
Kaiko, R. F. (1988) · Journal of Palliative Care · doi:10.1177/0825859788004001-221 · Cited by 11
Syringe driver in terminal care
Notcutt, W. G. (1987) · BMJ · doi:10.1136/bmj.294.6574.773-c · Cited by 7
Cited by
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Caraceni, A., Hanks, G., Kaasa, S., Bennett, M. I., Brunelli, C., Cherny, N., Dale, O., De Conno, F., Fallon, M., Hanna, M., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70040-2 · Cited by 1,243
Self-citationPrevalence of undertreatment in cancer pain. A review of published literature
Deandrea, S., Montanari, M., Moja, L., & Apolone, G. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn419 · Cited by 870
Davies, A. N., Dickman, A., Reid, C., Stevens, A., & Zeppetella, G. (2009) · European Journal of Pain · doi:10.1016/j.ejpain.2008.06.014 · Cited by 482
Management of cancer pain: ESMO Clinical Practice Guidelines
Ripamonti, C. I., Bandieri, E., & Roila, F. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr390 · Cited by 447
Self-citation
Metadata
- Authors
- Hanks, G. W., Conno, F. D., Cherny, N., Hanna, M., Kalso, E., McQuay, H. J., Mercadante, S., Meynadier, J., Poulain, P., Ripamonti, C., Radbruch, L., Casas, J. R. I., Sawe, J., Twycross, R. G., & Ventafridda, V
- Venue
- British Journal of Cancer
- Published
- 2001
- Volume
- 84
- Issue
- 5
- Pages
- 587-593
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2107448778
- Cited by
- 862
- References
- 27
- FWCI
- 26.26
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.